Literature DB >> 12793310

Cord blood from collection to expansion: feasibility in a regional blood bank.

M Elias1, N Choudhury, C Th Smit Sibinga.   

Abstract

This article reviews the various aspect of the experimental phase preceding the establishment of an umbilical cord blood (UCB) bank within a regular blood bank, a situation totally different from that of de novo establishing a cord blood bank having human and financial resources. An ethically approved two-year study has been conducted to determine the technical feasibility, and the practical problems that might be encountered such as public compliance, the additional workload, introduction of new activities ranging from collection and processing to progenitor expansion, infectious disease testing, development of a quality control system, record keeping and documentation, development of specific procedures and definitions of requirements. The cost benefit aspect, which will ultimately depend on the frequency of units release, was not considered in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12793310     DOI: 10.1007/bf02723589

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  THE BLOOD VOLUME OF THE NEWBORN INFANT AND PLACENTAL TRANSFUSION.

Authors:  R USHER; M SHEPHARD; J LIND
Journal:  Acta Paediatr       Date:  1963-09       Impact factor: 2.299

2.  The transfer of blood between baby and placenta in the minutes after birth.

Authors:  M GUNTHER
Journal:  Lancet       Date:  1957-06-22       Impact factor: 79.321

Review 3.  Marrow transplantation from donors other than HLA identical siblings.

Authors:  P G Beatty; C Anasetti
Journal:  Hematol Oncol Clin North Am       Date:  1990-06       Impact factor: 3.722

Review 4.  Stored placental blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; R E Rosenfield; J W Adamson; C E Stevens
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

5.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Rapid isolation and serum-free expansion of human CD34+ cells.

Authors:  J S Lebkowski; L Schain; M Hall; M Wysocki; B Dadey; W Biddle
Journal:  Blood Cells       Date:  1994

8.  Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.

Authors:  C De Bruyn; A Delforge; D Bron; P Ley; D de Hemptinne; P Stryckmans
Journal:  Stem Cells       Date:  1994-11       Impact factor: 6.277

9.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

10.  Separation of hematopoietic progenitor cells from human umbilical cord blood.

Authors:  A Nagler; M Peacock; M Tantoco; D Lamons; T B Okarma; D A Okrongly
Journal:  J Hematother       Date:  1993
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.